Similar articles

• Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson's disease.

  De Miranda BR, Miller JA, Hansen RJ, Lunghofer PJ, Safe S, Gustafson DL, Colagiovanni D, Tjalkens RB. De Miranda BR, et al. J Pharmacol Exp Ther. 2013 Apr;345(1):125-38. doi: 10.1124/jpet.112.201558. Epub 2013 Jan 14. J Pharmacol Exp Ther. 2013. PMID: 23318470 Free PMC article.
• Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.

  De Miranda BR, Popichak KA, Hammond SL, Miller JA, Safe S, Tjalkens RB. De Miranda BR, et al. Toxicol Sci. 2015 Feb;143(2):360-73. doi: 10.1093/toxsci/kfu236. Epub 2014 Nov 17. Toxicol Sci. 2015. PMID: 25406165 Free PMC article.
• Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.

  Pisanu A, Lecca D, Mulas G, Wardas J, Simbula G, Spiga S, Carta AR. Pisanu A, et al. Neurobiol Dis. 2014 Nov;71:280-91. doi: 10.1016/j.nbd.2014.08.011. Epub 2014 Aug 15. Neurobiol Dis. 2014. PMID: 25134730
• The neuroprotective effects of ferulic acid in toxin-induced models of Parkinson's disease: A review.

  Hassani S, Esmaeili A. Hassani S, et al. Ageing Res Rev. 2024 Jun;97:102299. doi: 10.1016/j.arr.2024.102299. Epub 2024 Apr 9. Ageing Res Rev. 2024. PMID: 38604452 Review.
• Lactoferrin/lactoferrin receptor: Neurodegenerative or neuroprotective in Parkinson's disease?

  Qian ZM, Li W, Guo Q. Qian ZM, et al. Ageing Res Rev. 2024 Nov;101:102474. doi: 10.1016/j.arr.2024.102474. Epub 2024 Aug 27. Ageing Res Rev. 2024. PMID: 39197711 Review.